The US Food and Drug Administration (FDA) has granted approval for Thermo Fisher Scientific’s Oncomine Dx Target Test as a treatment for non-small cell lung cancer (NSCLC). The test serves as a ...

SetPoint Medical has secured $140m through private financing, earmarked for the commercial rollout of the SetPoint System.

On 8 August, the US Food and Drug Administration (FDA) granted accelerated approval to Hernexeos (zongertinib) - a human epidermal growth factor receptor 2 (HER2) selective tyrosine kinase inhibitor - ...

Singapore-based HistoIndex has launched a new artificial intelligence (AI)-based laboratory developed test (LDT) in the US for measuring fibrosis in patients with metabolic dysfunction-associated ...

This year's Alzheimer's Association International Conference, which took place in Toronto, Canada from July 27-31 featured a range of data readouts from companies developing in vitro diagnostics (IVD) ...

US Food and Drug Administration (FDA) commissioner Martin Makary has announced that the IV fluid shortage for sodium chloride 0.9% injection products is now over after nearly a year of disruption.

In the first half (H1) of 2025, Abbott Laboratories performed well in the US medical device sector, with steady growth in its core product lines.